HighTower Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.64M | Buy |
235,066
+51,865
| +28% | +$2.46M | 0.01% | 949 |
|
|
2025
Q4 | $9.32M | Sell |
183,201
-8,034
| -4% | -$411K | 0.01% | 893 |
|
|
2025
Q3 | $10.6M | Sell |
191,235
-170,461
| -47% | -$9.98M | 0.01% | 821 |
|
|
2025
Q2 | $25M | Buy |
361,696
+28,330
| +8% | +$1.93M | 0.03% | 505 |
|
|
2025
Q1 | $23.1M | Sell |
333,366
-144,878
| -30% | -$12M | 0.03% | 489 |
|
|
2024
Q4 | $41.1M | Sell |
478,244
-1,529
| -0.3% | -$165K | 0.06% | 336 |
|
|
2024
Q3 | $57.1M | Sell |
479,773
-30,592
| -6% | -$4.08M | 0.08% | 248 |
|
|
2024
Q2 | $72.9M | Buy |
510,365
+31,697
| +7% | +$4.2M | 0.11% | 194 |
|
|
2024
Q1 | $61.5M | Sell |
478,668
-9,655
| -2% | -$1.15M | 0.1% | 221 |
|
|
2023
Q4 | $50.4M | Buy |
488,323
+50,144
| +11% | +$4.96M | 0.08% | 243 |
|
|
2023
Q3 | $39.9M | Buy |
438,179
+53,239
| +14% | +$4.69M | 0.07% | 260 |
|
|
2023
Q2 | $31.1M | Buy |
384,940
+53,072
| +16% | +$4.34M | 0.06% | 302 |
|
|
2023
Q1 | $26.4M | Sell |
331,868
-11,680
| -3% | -$828K | 0.06% | 326 |
|
|
2022
Q4 | $23.2M | Buy |
343,548
+17,576
| +5% | +$1.03M | 0.05% | 347 |
|
|
2022
Q3 | $16.2M | Buy |
325,972
+75,330
| +30% | +$4.04M | 0.04% | 400 |
|
|
2022
Q2 | $14M | Buy |
250,642
+21,722
| +9% | +$1.21M | 0.04% | 454 |
|
|
2022
Q1 | $12.7M | Buy |
228,920
+47,542
| +26% | +$2.44M | 0.03% | 530 |
|
|
2021
Q4 | $10.2M | Sell |
181,378
-47,808
| -21% | -$2.59M | 0.02% | 602 |
|
|
2021
Q3 | $11M | Buy |
229,186
+4,256
| +2% | +$206K | 0.03% | 505 |
|
|
2021
Q2 | $9.42M | Buy |
224,930
+12,828
| +6% | +$497K | 0.03% | 539 |
|
|
2021
Q1 | $7.13M | Buy |
212,102
+24,624
| +13% | +$877K | 0.02% | 608 |
|
|
2020
Q4 | $6.53M | Buy |
187,478
+38,878
| +26% | +$1.34M | 0.03% | 504 |
|
|
2020
Q3 | $5.14M | Buy |
148,600
+7,064
| +5% | +$235K | 0.02% | 545 |
|
|
2020
Q2 | $4.64M | Sell |
141,536
-13,670
| -9% | -$436K | 0.03% | 531 |
|
|
2020
Q1 | $4.66M | Buy |
155,206
+7,578
| +5% | +$226K | 0.03% | 472 |
|
|
2019
Q4 | $4.28M | Sell |
147,628
-1,762
| -1% | -$48.8K | 0.03% | 600 |
|
|
2019
Q3 | $3.89M | Buy |
149,390
+12,388
| +9% | +$313K | 0.02% | 655 |
|
|
2019
Q2 | $3.54M | Sell |
137,002
-37,728
| -22% | -$932K | 0.02% | 684 |
|
|
2019
Q1 | $4.59M | Sell |
174,730
-33,958
| -16% | -$835K | 0.03% | 533 |
|
|
2018
Q4 | $4.8M | Sell |
208,688
-2,012
| -1% | -$44.7K | 0.04% | 468 |
|
|
2018
Q3 | $4.94M | Sell |
210,700
-36,180
| -15% | -$883K | 0.04% | 511 |
|
|
2018
Q2 | $5.71M | Buy |
246,880
+26,210
| +12% | +$623K | 0.04% | 449 |
|
|
2018
Q1 | $5.43M | Sell |
220,670
-41,784
| -16% | -$1.1M | 0.05% | 445 |
|
|
2017
Q4 | $7.04M | Sell |
262,454
-13,292
| -5% | -$338K | 0.06% | 365 |
|
|
2017
Q3 | $6.64M | Buy |
275,746
+27,016
| +11% | +$610K | 0.06% | 379 |
|
|
2017
Q2 | $5.35M | Buy |
248,730
+22,090
| +10% | +$446K | 0.05% | 437 |
|
|
2017
Q1 | $3.88M | Buy |
226,640
+7,470
| +3% | +$130K | 0.04% | 522 |
|
|
2016
Q4 | $3.93M | Buy |
219,170
+156,546
| +250% | +$2.84M | 0.04% | 475 |
|
|
2016
Q3 | $1.3M | Buy |
62,624
+17,946
| +40% | +$445K | 0.02% | 819 |
|
|
2016
Q2 | $1.2M | Sell |
44,678
-204,132
| -82% | -$5.6M | 0.02% | 800 |
|
|
2016
Q1 | $6.74M | Buy |
248,810
+2,338
| +0.9% | +$62.6K | 0.02% | 294 |
|
|
2015
Q4 | $7.16M | Buy |
246,472
+91,242
| +59% | +$2.53M | 0.09% | 246 |
|
|
2015
Q3 | $4.21M | Buy |
155,230
+15,088
| +11% | +$427K | 0.06% | 366 |
|
|
2015
Q2 | $3.84M | Buy |
140,142
+111,428
| +388% | +$3.13M | 0.06% | 336 |
|
|
2015
Q1 | $769K | Sell |
28,714
-34,348
| -54% | -$791K | 0.01% | 907 |
|
|
2014
Q4 | $1.33M | Sell |
63,062
-158
| -0.2% | -$3.53K | 0.02% | 710 |
|
|
2014
Q3 | $1.5M | Sell |
63,220
-12,806
| -17% | -$295K | 0.03% | 635 |
|
|
2014
Q2 | $1.76M | Sell |
76,026
-13,058
| -15% | -$288K | 0.03% | 603 |
|
|
2014
Q1 | $2.03M | Buy |
89,084
+3,294
| +4% | +$70.2K | 0.04% | 510 |
|
|
2013
Q4 | $1.58M | Buy |
85,790
+14,440
| +20% | +$252K | 0.03% | 553 |
|
|
2013
Q3 | $1.21M | Buy |
71,350
+850
| +1% | +$14.3K | 0.03% | 573 |
|
|
2013
Q2 | $1.09M | Buy |
+70,500
| New | +$1.17M | 0.03% | 572 |
|
Other funds holding NVO
DAM
F
HighTower Advisors's NVO Position: Q1 2026 in Review
HighTower Advisors increased its Novo Nordisk (NVO) stake by 28% in Q1 2026, buying an estimated $2.46M and bringing the position to 235,066 shares worth $8.64M. The position accounts for 0.01% of the portfolio, ranked #949.
HighTower Advisors first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $72.9M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- HighTower Advisors held 235,066 shares of Novo Nordisk worth $8.64M as of Q1 2026.
- HighTower Advisors bought 51,865 Novo Nordisk shares in Q1 2026, an estimated $2.46M.
- Novo Nordisk made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #949 holding.
- HighTower Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
- HighTower Advisors's Novo Nordisk position peaked at $72.9M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.